Key Market Indicators
Greek analgesic medicine sales are set to rise to $205.55 million by 2026, up from $177.98 million in 2021, according to a CAGR of 1.9%. Since 2003, the Greek market has grown by an average of 2.3% year-on-year. In 2021, Greece was ranked 10th in the world for analgesic medicines, with Norway overtaking Greece at $177.98 million. Spain, Canada and Italy came in second, third and fourth, respectively.
